Latest News

Curosurf Annoucement

Effective from 6 March, 2014 EMERGE HEALTH PTY LTD a specialty medicines company, today announced it has the exclusive marketing and distribution rights of Curosurf® in Australia. Curosurf® (poractant alfa) is indicated for the treatment (rescue) of Respiratory Distress Syndrome (RDS) in premature infants and for prophylactic use in infants at risk of RDS About .. read more

On March 7th, 2014, posted in: Latest News, Neonatal Medicine by

Meningitec Announcement

January 20, 2014 Melbourne, Australia: – EMERGE HEALTH PTY LTD a specialty medicine company, today announced that it has become the Market Authorisation holder and exclusive distributor of Meningitec™ (originally from Pfizer) in an exclusive distribution deal for Australia and New Zealand with Nuron Biotech, a US based biotechnology company focused on developing novel biologics .. read more

On January 24th, 2014, posted in: Latest News by

Winner of Emerge Health’s competition held at the 39th SHPA National Conference

Only logged in healthcare professionals can view this post!

On October 14th, 2013, posted in: Latest News by

Availability of Cyclophosphamide Tablets

Only logged in healthcare professionals can view this post!

On October 11th, 2013, posted in: Latest News by

Emerge Health announces Winners of the SHPA 2012 Competition

Only logged in healthcare professionals can view this post!

On April 24th, 2013, posted in: Latest News by